Souhaitez-vous accéder aux communiqués récents ?

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204

PALO ALTO, Calif. and TEL AVIV, March 26, 2026 (GLOBE NEWSWIRE) -- Exodigo, the artificial intelligence (AI) and multi-sensing innovator transforming underground data intelligence, today announced...

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist

Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Decentralized Clinical Trials: Global Markets" has been added to ResearchAndMarkets.com's offering. The Decentralized Clinical Trials Market is...

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

Anthony Chadd joins Zimbra as CRO to scale global sales, marketing, and partner ecosystems.

ORLANDO, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Worth, the fintech platform modernizing onboarding and underwriting for financial institutions, today announced the appointment of fintech veterans,...

Skyhawk Security appoints new CRO, Jason Schaaf, lauding past success at ActiveFence and CyberX.

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, continues to accelerate clinical trial...

PEABODY, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Access, a global, privately-held integrated information management solutions provider, today announced that Aditya Udas has joined the company as...